Skip to content
    Clinical Trials

    Opioid-free anesthesia improves recovery in gynecological cancer surgery, trial finds

    Kanchan et alCureus

    Opioid-free anesthesia improves recovery in gynecological cancer surgery, trial finds
    In a randomized controlled trial involving 80 ASA-PS I-II patients aged 20–65 years undergoing exploratory laparotomy for gynecological cancer, investigators evaluated the impact of opioid-free anesthesia (OFA) versus opioid-based anesthesia (OBA) on early postoperative recovery. Patients were randomized into two equal groups of 40: Group OF received intravenous dexmedetomidine and ketamine infusions, while Group OB received IV morphine. All patients underwent general anesthesia with epidural catheter placement and received epidural analgesia for 48 hours postoperatively. Patients with chronic pain, prior opioid use, history of PONV, coagulopathy, local anesthetic allergy, or cognitive dysfunction were excluded.
    The primary outcome was Quality of Recovery assessed using the QoR-40 questionnaire. Secondary outcomes recorded through postoperative day three included Numerical Rating Scale (NRS) pain scores, rescue analgesia requirements, postoperative nausea and vomiting (PONV), hemodynamic parameters, time to first ambulation, DN-4 scores, oral fluid tolerance, and length of hospital stay.
    Patients in the OFA cohort demonstrated significantly superior QoR-40 recovery scores compared to the OBA cohort. In addition, the incidence of PONV was significantly lower in the OFA group during the first eight hours postoperatively. No statistically significant differences were observed between groups in NRS pain scores, rescue analgesic consumption, intraoperative or postoperative hemodynamic parameters, time to first ambulation, oral fluid tolerance, or duration of hospital stay.

    Key Takeaways

    • Opioid-free anesthesia utilizing dexmedetomidine and ketamine infusions significantly improved postoperative Quality of Recovery (QoR-40) compared with morphine-based anesthesia in patients undergoing exploratory laparotomy for gynecological cancer.
    • Postoperative nausea and vomiting was significantly lower in patients receiving opioid-free anesthesia for up to eight hours postoperatively compared to those receiving opioid-based anesthesia.
    • No significant differences were observed between opioid-free and opioid-based anesthesia regarding pain scores, rescue analgesic requirements, time to ambulation, oral fluid tolerance, or length of hospital stay.